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Recombinant human osteopontin 
expressed in Nicotiana benthamiana 
stimulates osteogenesis related 
genes in human periodontal 
ligament cells
Kaewta Rattanapisit1, Supaniga Abdulheem2, Daneeya Chaikeawkaew2, Anchanee Kubera3, 
Hugh S. Mason4, Julian K-C Ma5, Prasit Pavasant2 & Waranyoo Phoolcharoen1
Tissue engineering aims to utilise biologic mediators to facilitate tissue regeneration. Several 
recombinant proteins have potential to mediate induction of bone production, however, the high 
production cost of mammalian cell expression impedes patient access to such treatments. The aim of 
this study is to produce recombinant human osteopontin (hOPN) in plants for inducing dental bone 
regeneration. The expression host was Nicotiana benthamiana using a geminiviral vector for transient 
expression. OPN expression was confirmed by Western blot and ELISA, and OPN was purified using 
Ni affinity chromatography. Structural analysis indicated that plant-produced hOPN had a structure 
similar to commercial HEK cell-produced hOPN. Biological function of the plant-produced hOPN was 
also examined. Human periodontal ligament stem cells were seeded on an OPN-coated surface. The 
results indicated that cells could grow normally on plant-produced hOPN as compared to commercial 
HEK cell-produced hOPN determined by MTT assay. Interestingly, increased expression of osteogenic 
differentiation-related genes, including OSX, DMP1, and Wnt3a, was observed by realtime PCR. These 
results show the potential of plant-produced OPN to induce osteogenic differentiation of stem cells 
from periodontal ligament in vitro, and suggest a therapeutic strategy for bone regeneration in the 
future.
Tissue engineering is a technology in medical therapeutics using bioactive substitutes for functional restoration 
of lost tissues and impaired organs1. Various proteins are necessary for tissue or organ engineering. These proteins 
function in regulating cellular behavior, the structure of many signaling molecules, and the fabrication of scaf-
folds2. However, there are several limitations to using proteins for this objective, such as source availability and 
stability, batch-to-batch variability, transmission of infecting organisms and immunogenicity3,4. Recombinant 
DNA technology used to expression foreign genes in convenient host systems can overcome these impediments.
Many recombinant proteins were reported to function in tissue engineering, such as bone matrix protein, col-
lagens5,6, elastin7,8, and spider silk9,10. Presently, several sources for recombinant protein production are available, 
including E. coli, yeast, insect cells, mammalian cells, and plants. Among these platforms, the plant system is the 
most recently developed. One advantage of plants over other systems is eukaryotic post-translational modifica-
tion, which may be necessary for the function of proteins used in tissue engineering processes11. Other advantages 
include lack of human pathogens, speed, low cost, and highly scalable manufacturing11,12.
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OPN has a role in bone formation. Also known as secreted phophoprotein1 (SPP1), it is a highly phosphoryl-
ated glycoprotein that is a prominent component of the mineralized extracellular matrix of bone13. OPN contains 
an Arg-Gly-Asp sequence that is a major integrin-binding site and functions to support adhesion of bone cells to 
the mineralized matrix14,15. The molecular weight of OPN varies between 45–74 kDa, depending on the level of 
phosphorylation and glycosylation16. OPN is a soluble protein present in most body fluids. One study suggested 
that OPN plays a role in adhesion and movement of osteoblasts in bone17. Besides bone cells, OPN can be secreted 
by mesenchymal stem cells (MSC) and can be further up-regulated during the osteogenic differentiation of these 
cells18.
In this study, plants are used to produce human osteopontin (hOPN) as a model for recombinant proteins for 
tissue engineering. The recombinant hOPN was expressed transiently in Nicotiana benthamiana using geminivi-
ral vectors. The hOPN was purified by Ni affinity chromatography and characterized for its structural conforma-
tion compared with commercial hOPN. The effect of plant-produced hOPN on cell cytotoxicity and osteogenic 
differentiation were also investigated.
Results
Transient expression of hOPN in N. benthamiana leaves. We produced hOPN by co-expression of 
hOPN (geminiviral vector pBY-OPN) with the gene silencing inhibitor p1919 from tomato bushy stunt virus, 
pPS19 (Fig. 1). The expression level of hOPN in N. benthamiana leaves was examined from 1 to 5 dpi by Western 
blot. The highest level of protein expression was found on day 3 (Supplementary Figure 1), up to ~100 ng hOPN 
per g leaf mass. Therefore, leaves were subsequently harvested on day 3 for protein extraction and purification. 
hOPN protein was observed at ~50 kDa by Western blot using anti-OPN antibody, while a negative control leaf 
extract showed no signal (Fig. 2A). The hOPN protein was purified from plant leaves using Ni affinity chromatog-
raphy. The purified protein was confirmed by Western blot using an anti-OPN antibody (Fig. 2B) and SDS-PAGE 
(Fig. 2C).
Secondary structure comparison by CD spectroscopy. To verify the secondary structure, the CD 
spectra of commercial hOPN expressed in HEK 293 cells and plan-produced hOPN were monitored. The sec-
ondary structure contents of both proteins are showed in Table 1. The spectrum of both proteins had peaks at 
wavelengths of 208 nm and 222 nm (Fig. 3). These spectra suggested that both proteins contain similar secondary 
structures.
Tertiary structure comparison by fluorescence spectroscopy. The intrinsic tryptophan fluorescence 
spectra of commercial hOPN expressed in HEK 293 cells and plant-produced hOPN were characterized (Fig. 4). 
The maximum wavelengths of commercial hOPN and plant-produced hOPN were 340 and 320 nm, respectively. 
This result implied that the overall tertiary structure including the structure of glycosylation of these proteins 
were different.
Effect of plant-produced hOPN on cell proliferation. The effect of OPN on cell proliferation was 
examined by culturing hPDL cells established from 3 different donors on plant-produced hOPN-coated surface 
compared to cell culture on gelatin-coated and commercial hOPN-coated surfaces. The cell number was deter-
mined by MTT assay after cultured for 1, 2 and 3 days. The results showed that all 3 lines of hPDL cells could 
attach and grew normally on all surfaces tested (Fig. 5) indicating that none of the materials tested cytotoxic. 
However, cells cultured on 5 and 9 ng/ml of plant-produced hOPN grew significantly faster than when cultured 
on 9 ng/ml of gelatin on day 2 and day 3.
Plant-produced hOPN activates osteogenesis related genes. Cells were treated with 1, 5 and 9 ng/
ml of plant-produced hOPN or 9 ng/ml commercial hOPN for 72 hours. The mRNA was extracted and tested 
for the expression of OSX, DMP1, and Wnt3a genes by qRT-PCR. Figure 6 shows the expression level of these 
genes compared to cells cultured on gelatin with commercial OPN 9 ng/ml. The results from Fig. 6 indicated that 
commercial hOPN–coated surface could up-regulate the expression of OSX, DMP1, and Wnt3a. Interestingly, the 
mRNA expression of these three genes in cells seeded on plant-produced hOPN were significantly higher than 
those found in cells seeded on either gelatin-coated or 9 ng/ml commercial hOPN-coated surfaces.
Figure 1. Schematic representation of the T-DNA regions of the vectors used in this study P35S: Cauliflower 
Mosaic Virus (CaMV) 35S promoter, O. sativa leader: Oryza sativa leader sequence, OPN: human osteopontin 
gene with 8X histidine residues at C-terminus, vspB3’: soybean vspB gene 3′ element, C2/C1: Bean Yellow 
Dwaft Virus (BeYDV) ORFs C1 and C2 which encode for replication initiation protein (Rep) and RepA, LIR: 
long intergenic region of BeYDV genome, SIR: short intergenic region of BeYDV genome, NPTII: expression 
cassette encoding nptII gene for kanamycin resistance P19: P19 gene from Tomato Bushy Stunt Virus (TBSV). 
LB and RB: the left and right borders of the Agrobacterium T-DNA region.
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Figure 2. Western blot and SDS-PAGE of plant-produced hOPN. (A)Western blot of hOPN in crude extract of 
N. benthamiana leaf agroinfiltrated with pBY-OPN and pPS19 detected with mouse anti-human OPN and goat 
anti-mouse IgG conjugated with HRP. lane 1: wildtype N. benthamiana, lane 2: N. benthamiana agroinfiltrated 
with pBY-OPN and pPS19; (B) Western blot of purified hOPN from N. benthamiana detected with mouse anti-
human OPN and goat anti-mouse IgG conjugated with HRP. lane 1: hOPN produced from HEK 293 cells, lane 
2: wildtype N. benthamiana, lane 3: N. benthamiana agroinfiltrated with pBY-OPN and pPS19; (C) Purified 
plant-produced hOPN in SDS-PAGE. The numbers on the left are the size of the protein marker in kDa.
Secondary structure 
contents (%)
hOPN produced from 
HEK 293 cells
hOPN produced from 
N. benthamiana
α-helix 2.5 8.3
β-sheet 34.3 28.1
turn 12.5 12.5
random 40.3 39.2
sum 89.7 88.1
Table 1. The estimated secondary structure contents of commercial hOPN and plant hOPN.
Figure 3. CD Structure analysis. Circular dichroism spectra of plant-produced hOPN and commercial hOPN 
(7.7 μM) in PBS (pH 7.4) were scanned by a circular dichroism spectrometer from 200–250 nm at. Both proteins 
exhibited maximum wavelength at 210 nm.
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Figure 4. Intrinsic fluorescence spectra of commercial hOPN and plant-produced hOPN. Plant-produced 
hOPN showed blue shift of the maximum wavelength when compared to the commercial hOPN. The emission 
spectra were obtained from 320–500 nm, with the excitation wavelength at 280 nm.
Figure 5. Effect of OPN on periodontal ligament cells (PDL) proliferation. Three PDL cell lines established 
from three different donors were cultured on gelatin-coated (9 ng/well), commercial hOPN-coated (9 ng/well) 
and plant-produced hOPN-coated surface (1. 5 and 9 ng/well) for 1–3 days. The experiments were done in 
triplicated. Cell survival was evaluated by MTT assay at 24 hours. Data represented the absorbance at 540 nm. 
Data are means of 3 independent replicate samples +/−SD. Control in this experiment is the untreated cells. 
(*p ≤ 0.05).
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Discussion
In this study, we have demonstrated that functional matrix protein hOPN could be produced in N. benthamiana. 
The plant-produced hOPN was purified by Ni affinity chromatography and characterized by Western blot analysis 
and ELISA. The molecular weight of plant-produced hOPN was approximately 50 kDa, which is similar to that 
found in human tissue20,21. Our results also indicated that plant-produced hOPN contained similar epitopes as 
the protein synthesized by mammalian cells as judged by the ability to be recognized by a monoclonal anti-human 
OPN (Fig. 2B). Interestingly, plant produced hOPN showed increased biological function regarding osteogenic 
differentiation as compared to the same amount of recombinant hOPN from HEK cells (Fig. 6).
Recombinant hOPN was previously expressed in E. coli22–25. Although hOPN produced from E. coli showed 
activity in cell adhesion, proliferation and differentiation of osteoblast cells23, it has been shown that the 
post-translational modifications of recombinant hOPN affects the biological activities related to the regulation 
of cell adhesion regulation26, which is necessary for bone regeneration. Therefore, a production platform that can 
provide effective post-translational modification is needed for recombinant hOPN production.
This is the first study showing that plants can be used as a platform to produce hOPN. The geminiviral repli-
con system has previously been used to produce different proteins such as antibody27,28, antigens28, and immune 
Figure 6. Plant-produced hOPN increased the mRNA expression of osteogenic markers. PDL cells from three 
different donors were treated with of 9 ng/ml gelatin, 9 ng/ml commercial hOPN, and 1, 5, 9 ng/ml plant-
produced hOPN for 24 hours. Total RNA was extracted and real time PCR was performed using primer sets 
for human OSX, DMP1, and Wnt3a genes. Relative mRNA expression values were calculated normalized to 
the cells treated with gelatin. The values obtained for control gelatin were set at 1 for subsequent fold change 
calculation. (*p ≤ 0.05 compared to 9 ng/ml gelatin, #p ≤ 0.05 compared to 9 ng/ml commercial hOPN).
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complex29. In this study, the geminiviral vector resulted in rapid transient expression - only 3 days after trans-
fection. Although the expected mass of the unmodified hOPN protein is 33 kDa, posttranslational modifications 
increase the molecular weight to 45–75 kDa depending on conditions30. Our result showed that plant-produced 
hOPN is approximately 50 kDa (Fig. 2). OPN contains both N-linked and O-linked glycosylation sites31. Two 
N-glycan sites were found in OPN from bone, kidney tissues, macrophages, urinary stones and human milk32. 
Seven O-glycosylation regions were detected on hOPN, which are occupied by highly heterogeneous O-glycans33. 
A previous study demonstrated that the O-glycosylation of hOPN regulated its biological activities and affected 
the phosphorylation status34.
We used circular dichroism (CD) to evaluate the secondary structure of both commercial hOPN and 
plant-produced hOPN (Fig. 3). These data confirmed the similarity of secondary structures between hOPN pro-
duced from mammalian cells and plants. However, the intrinsic fluorescence spectra of these proteins were found 
to be somewhat different (Fig. 4). Since hOPN is a glycosylated protein, the different glycosylation patterns in 
human and plant may affect the overall protein conformation. This result is consistent with several reports that 
some proteins with different patterns of glycosylation showed shifted spectra35,36.
The biological activity of the purified plant-produced hOPN was further examined in human periodontal 
ligament stem cells. OPN has been shown to contain an RGD amino acid sequence that promotes cell attach-
ment via integrin alphavbeta3. In this study, the ability to support cell growth and attachment was compared 
between gelatin, denatured type I collagen, commercial recombinant hOPN and plant-produced OPN using PDL 
cells. No significant differences were detected after 24 hours in culture. However, cells cultured on the plant pro-
duced hOPN-coated surface had significantly increased cell proliferation after 2 and 3 days in culture (Fig. 5). 
Interestingly, both types of hOPN, when immobilized on the cell surface using layer-by-layer technique, could 
significantly induce expression of osteogenic related genes such as OSX, DMP1, and Wnt3a (Fig. 6). Wnt3a is a 
the key protein to induce osteogenic differentiation of MSCs37, while osterix (OSX) is the key transcription factor 
that functions in osteogenic differentiation38. Dentine matrix acidic phosphoprotein-1 (DMP-1) is also one of 
the matrix proteins that has been recognized as a marker of mineralized tissue formation39. The ability of OPN 
to support osteogenic differentiation has been reported previously39. In that report, addition of a neutralizing 
antibody to OPN affected osteogenic differentiation of bone marrow mesenchymal stem cells. Our data showed 
the stimulation of these osteogenic related genes in cells isolated from three different donors. Three different 
donors are a minimum number for statistical analysis and were used in several reported studies40–43. Therefore, 
the plant-produced hOPN has clinical potential for supporting the osteogenic regeneration process.
It is also interesting to note that, at the same concentration, 9 ng/ml, the plant-produced OPN induced DMP1, 
OSX, and Wnt3a genes significantly better than commercial hOPN (Fig. 6) in all three established hPDL from 
3 different donors, by a factor of 5–10 times. The levels of induction are different among the donor cells due to 
individual genetic variation. Although the exact mechanism is still unclear, it is possible that the plant-specific 
glycan pattern might be involved. Thus the glycan structures of plant-produced hOPN will be studied in detailed 
in future.
Our study firstly reported that the recombinant hOPN protein can be produced in plants by transient expres-
sion and the plant-produced hOPN can induce the genes involved in bone regeneration in cellulo. Further study of 
the plant-produced hOPN in an animal model is necessary to evaluate function in bone regeneration. Moreover, 
other proteins, which induce a different mechanism of bone regeneration, will also tested for expression in plants. 
The plant platform has potential to be a robust factory to produce low cost and effective recombinant proteins, 
which can facilitate the development of tissue engineering techniques that are affordable for patients in the future.
Methods
Expression vector construction. Human osteopontin gene44 was amplified using hOPN forward and 
hOPN reverse primers (Table 2). The vector containing human OPN was a gift from Professor Cecilia M. 
Giachelli. The PCR product was cloned into pGEM-T Easy (Promega, USA) for sequencing and cut with NcoI 
and SacI restriction enzymes. The geminiviral vector pBY030.2R45 was cut with NcoI and SacI and ligated with 
the digested hOPN gene to make pBY-OPN (Fig. 1). After verification, the plasmid was electroporated into 
Agrobacterium tumefaciens strain GV3101.
Gene Sequence (5′ to 3′) Product size (bp) Sequence ID
hOPN
Forward: CCATGGAACTTGGACTTTCTTGG
950 J04765.1
Reverse: GAGCTCTTAATGATGGTGATGGTGGTGATGATG
qGAPDH
Forward: CACTGCCAACGTGTCAGTGGTG
121 NM_002046.5
Reverse: GTAGCCCAGGATGCCCTTGAG
OSX
Forward: GCCAGAAGCTGTGAAACCTC
160 NM_152860.1
Reverse: GCTGCAAGCTCTCCATAACC
qDMP-1
Forward: ATGCCTATCACAACAAACC
213 NM_004407.3
Reverse: CTCCTTTATGTGACAACTGC
Wnt3a
Forward: CTGTTGGGCCACAGTATTCC
113 NM_033131.3
Reverse: GGGCATGATCTCCACGTAGT
Table 2. Primers list.
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Plant inoculation and protein expression. Nicotiana benthamiana plants, 6 to 8 weeks-old, were 
co-infiltrated with two Agrobacterium cell lines that contained pBY-OPN or pPSp19 by vacuum infiltration27. 
Plants were maintained in cultured room with a 16 h light/8 h dark cycle at 28 °C after infiltration. The leaves were 
harvested on days 1, 2, 3, 4, and 5 post-infiltration (dpi) for expression time-course experiments. For other exper-
iments, the leaves were harvested on day 3 dpi. Infiltrated tobacco leaves were homogenized by using a blender 
with extraction buffer (5 mM imidazole, 20 mM Tris-HCl pH 7.4, 50 mM NaCl). Crude extract was filtered 
through Miracloth and centrifuged at 26,000 g at 4 °C for 30 min. The supernatant was filtered with 0.2-micron 
filter and used for Ni affinity purification. Chelating SepharoseTM (GE healthcare, UK) was packed into a column 
and washed with 10 bed volumes of distilled water. The resin was charged with 5 column volumes (CV) of 50 mM 
NiSO4.6H2O. After washing with 10 CV distilled water, the resin was washed with 10 CV of binding buffer (5 mM 
imidazole, 20 mM Tris-HCl pH7.4, 50 mM NaCl). The plant extract solution was loaded into the column. After 
washing with 10 CV washing buffer (20 mM imidazole, 20 mM Tris-HCl pH7.4, 50 mM NaCl), the purified pro-
tein was eluted with eluting buffer (250 mM imidazole, 20 mM Tris-HCl pH7.4, 50 mM NaCl) and analyzed by 
SDS-PAGE and Western blot.
SDS-PAGE and Western blot. The proteins were denatured by boiling for 5 minutes with loading buffer 
(125 mM Tris-HCl, 12% (w/v) SDS, 10% (v/v) glycerol, 22% (v/v) β-mercaptoethanol, and 0.001% (w/v) bromo-
phenol blue) and separated on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE). 
Proteins were either visualized by Coomassie blue staining or electrophoretically transferred to polyvinlidene dif-
luoride (PVDF) membrane (Amersham Hybond-ECL; Amersham Biosciences, UK). The membrane was blocked 
with 5% non-fat dried milk, 0.1% Tween20 in PBS (PBST). The membrane was probed with mouse monoclo-
nal anti-OPN antiserum (Abcam, UK) diluted 1:5,000 in 1% non-fat dried milk in PBST and goat anti-mouse 
IgG-HRP conjugated (Sigma, USA) diluted 1:10,000 in 1% non-fat dried milk in PBST. The membranes were 
developed by chemiluminescence using ECL plus detection reagent (GE Healthcare, UK).
Secondary structure characterization by circular dichroism spectroscopy. Circular dichroism 
(CD) spectra were recorded by Chirascan (Applied Photophysics, Ltd) to determine the secondary structure of 
recombinant hOPN expressed in HEK 293 cells (Sigma-Aldrich, USA) and plant-produced hOPN. The spectra 
were measured between 190 nm and 250 nm. The measurements were conducted using protein concentrations 
of 0.10 mg/mL in 10 mM potassium phosphate buffer (pH 7.4). All data presented are the means of three inde-
pendent measurements. The secondary contents of both proteins were calculated using Raussens et al. method46.
Intrinsic fluorescence spectroscopy. Emission spectra of commercial hOPN and plant-produced hOPN 
were monitored. The spectra were scanned from 300 to 500 nm using Spark 10 M multimode microplate reader 
(Tecan Group Ltd., Männedorf, Switzerland), based on an excitation of intrinsic fluorescence from aromatic side 
chains at 280 nm. Samples containing 0.10 mg/ml of protein were analyzed. Three repetitive scans were obtained 
and averaged.
OPN quantification by ELISA. The purified plant-produced hOPN was quantified by ELISA. The protocol 
was done according to manuals of Human Osteopontin (OPN) ELISA Kit (Sigma-Aldrich, USA). The absorbance 
was measured using microplate reader at 450 nm.
Cells. Human periodontal ligament (hPDL) cells were isolated and maintained according to a previous 
report47. The protocol was approved by the Ethics Committee, Faculty of Dentistry, Chulalongkorn University 
and all methods were performed in accordance with the relevant guidelines and regulations. The informed con-
sents were obtained. Briefly, periodontal tissues were scraped from the middle one-third of the root surface the 
extracted third molars. The explants were cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal 
bovine serum, 2 mM L-glutamine, 100 units/mL penicillin, 100 µg/mL streptomycin and 250 ng/mL ampho-
tericin B at 37 °C in a humidified 5% carbon dioxide atmosphere until the cells were outgrown from the explants 
and routinely subcultured after reaching confluency. All cell culture reagents were purchased from Gibco BRL 
(Carlsbad, CA, USA). Cells were prepared from six donors, represented by line A, B, C, D, E, and F. All the 
experiments were done using cells from passage 3–5. To characterize the mesenchymal surface markers, flow 
cytometry was performed to determine the surface expression of CD45, CD73, CD90 and CD105 according to 
our previously published report48,49.
Cell proliferation assay. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (USB 
Corporation, USA) is a tetrazolium compound that will be reduced to a formazan product by mitochondrial 
dehydrogenase. The amount of formazan product represents the metabolic activity of viable cells at a particular 
time point. Thus, cell proliferation can be indirectly determined by the changes in the amount of formazan. 
Cells were seeded at density of 50,000 cells per wells in 24-well-plate and assay was performed at days 24, 48, 
or 72 hours. Cells were treated with 300 µl of 0.5 mg/ml MTT solution and the plate was incubated for 20 min at 
37 °C. After that, the MTT solution was aspirated and the well washed with PBS. Then 500 µl of Glycine:DMSO 
(1:9) was added to each well. After the formazan crystals had dissolved, the absorbance was determined spectro-
photometrically at 570 nm using a reference wavelength of 630 nm on an ELX800UV universal microplate reader 
(Bio-Tek Instruments Inc., Vermont, USA). The experiments were done in triplicate.
Real-time PCR analysis for osteoblast differentiation markers. Total RNA was extracted from each 
experiment with Isol-RNA Lysis reagent (5Prime, Gaithersburg, MD, USA) and 1 µg of RNA per sample was 
converted to cDNA using a reverse transcriptase kit (Promega, Madison, WI, USA). Real-time quantitative pol-
ymerase chain reaction was performed using a Lightcycler Nano realtime polymerase chain reaction machine 
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(Roche Applied Science, Indianapolis, IN, USA) using FastStart Essential DNA Green Master (Roche Applied 
Science). The PCR protocol was set as; denaturation at 94 °C for 10 seconds, annealing at 60 °C for 10 seconds, and 
extension at 72 °C for 10 seconds for 45 cycles. The reaction product of GAPDH was used as a reference gene for 
the internal control. The primer sequences are shown in Table 2.
Statistical Analysis. All experiments were performed using cells isolated from three different donors. 
Statistical evaluation was performed using SPSS 16.0 software (SPSS, USA). The Mann Whitney U test was 
employed for two group comparison and the Kruskal Wallis test followed by pairwise comparison was used for 
comparing three or more groups. A significant difference was considered at p ≤ 0.05.
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